Use of mammotome system in diagnose of early breast cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 9, 2007, Pages 706-708

  Li, Yu Yang ^a   Hong, Fan Zhen ^a   Wang, Yong Sheng ^b   Zhong, Wei Xia ^b   Zuo, Wen Shu ^b  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Breast neoplasms diagnosis; Breat neoplasms surgery; Follow up studies; Immunohistochemistry; Surgical procedures, minimally invasive

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMOTOME BIOPSY; PROBABILITY; PROTEIN EXPRESSION; RELIABILITY;

EID: 77950691348     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Dumitrescu R G, Cotarla I. Understanding breast cancer risk - where do we stand in 2005? [J]. J Cell Mol Med, 2005, 9 (1): 208-221.
2. Noguchi M. Minimally invasive surgery for small breast cancer [J]. Surg Oncol,2003,84(2):94-101.
3. Zagorianakou P, Fiaccavento S, Zagorianakou N, et al. FNAC: its role, limitations and perspective in the preoperative diagnosis of breast cancer[J]. Eur J Gynaecol Oncol, 2005,26(2):143-149.
4. Matsuzaki S, Shiba E, Kobayashi Y, et al. Stereotactic vacuum-assisted breast biopsy (Mammotome biopsy) for non-palpable microcalcification on mammography[J]. Nippon Igaku Hoshasen Gakkai Zasshi,2005,65(1):16-22.
5. Della-Sala S W, Pellegrini M, Bernardi D, et al. Advantages and limits of percutaneous breast core biopsy with Mammotome and stereotactic equipment in upright seated patient[J]. Radiol Med (Torino),2004,108(4):335-344.
6. Morrow M, Strom E A, Bassett L W, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma[J]. CA Cancer J Clin,2005,52(5):277-300.
7. Arens N, Bleyl U, Hildenbrand R. HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer[J]. Virchows Arch, 2005, 446 (5): 489-496.
8. Pu R T, Schott A F, Sturtz D E, et al. Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis [J]. Am J Surg Pathol, 2005, 29(3): 354-358.